Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 81-100 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 81 | Atomic-6 lowweak | Opp 4 Risk 5 | Thesis: Atomic-6 appears to have meaningful strategic upside because the membership rationale says it launched an orbital data center service and has DoD and U.S. Space Force contracts, which would support a long-duration defense/space infrastructure thesis if confirmed. Why now: The reviewed sources rationale cites article and says Atomic-6 launched an orbital data center service and has DoD and U.S. Space Force contracts, but no representative article or is provided in the visible reviewed sources, so timing confidence is limited. Caveats: No direct evidence or article are available in the reviewed sources body. Opportunity thesis relies on membership rationale rather than citable article summary. Because the underlying evidence is not exposed, conviction must stay low. |
| 82 | Beijing Guodian High-Tech Technology Co lowweak | Opp 4 Risk 2 | Thesis: Reviewed evidence rationale says the company received approval for a commercial satellite IoT pilot program using the Tianqi constellation of 41 satellites. Regulatory or pilot approval tied to an existing constellation is a meaningful long-horizon opportunity signal if execution follows. Why now: The implied catalyst is the pilot-program approval, but the reviewed sources provide no retained article summary or timestamped evidence row beyond the membership rationale. Caveats: Phase2 membership rationale references: but the actual summary/evidence are absent. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Opportunity score is restrained because approval alone is described in rationale but not directly evidenced here. |
| 83 | D-Orbit lowweak | Opp 4 Risk 3 | Thesis: Moderate evidence-ranked opportunity: the reviewed sources membership rationale says D-Orbit partnered with Magdrive for an electric propulsion demo and places the company in satellite propulsion/orbital logistics, which suggests active technology development aligned with durable LEO and sustainability themes over a 1 year+ horizon. Why now: Why now is the partnership/demo claim referenced in article ID, but the reviewed sources includes neither nor explicit article timing beyond the article ID prefix, limiting recency precision. Caveats: Opportunity rests on membership rationale rather than fully available direct evidence. Referenced article ID has no in the reviewed sources. Demo activity is not the same as proven commercial traction. |
| 84 | Dhruva Space lowweak | Opp 4 Risk 2 | Thesis: Among this screen, Dhruva Space has one of the stronger reviewed sources rationales: it is described as having received a government grant for Project Garud, a 500 kg-class satellite platform for constellation-scale missions, and later partnering with ICEYE on satellite systems and Earth observation services. If current, those items imply platform and partnership traction that could matter over a 1 year+ horizon. Why now: The reviewed sources references: and: in the membership rationale, suggesting relatively recent strategic developments, but the coverage report still shows zero evidence after recent evidence window, so timing confidence is limited. Caveats: Positive thesis relies on membership rationale, not available direct evidence. Partnership evidence cannot be expanded through relation propagation beyond what is explicitly stated. |
| 85 | EDGX lowweak | Opp 4 Risk 3 | Thesis: Reviewed evidence rationale indicates EDGX is a Belgian spacetech startup with a prior €2.3M seed round and an in-orbit demonstration of its STERNA AI computing system on SpaceX Transporter-16. If still current, in-orbit validation plus prior funding can support a longer-horizon commercialization opportunity. Why now: The membership support references articles, and, implying a narrative of funding plus orbital demonstration, but active evidence remains empty after recent evidence filtering, limiting recency confidence. Caveats: In-orbit demo claim appears only in reviewed sources rationale, not available direct evidence. No evidence confirms whether the prior seed round falls within the current decision horizon relevance. No direct adverse evidence is present, but that is not proof of low fundamental risk. |
| 86 | Ellipsis Drive lowweak | Opp 4 Risk 3 | Thesis: Moderate opportunity on sparse evidence: the reviewed sources membership rationale describes Ellipsis Drive as addressing an Earth observation satellite-data processing bottleneck, with support from space agencies and target users including Earth observation firms. If accurate, that points to a software-layer position that could benefit over a 1 year+ adoption cycle. Why now: Why now is the reviewed sources' claim that the company addresses a key EO data-processing bottleneck and has space-agency support, referenced to article ID: though no or timestamp detail was provided. Caveats: Claims come from membership rationale rather than direct evidence. Referenced article ID: lacks a reviewed sources. Support from agencies and target users is weaker than demonstrated contracted revenue. |
| 87 | Eta Space lowweak | Opp 4 Risk 2 | Thesis: Eta Space has reviewed sources support that its LOXSAT mission will demonstrate 11 cryogenic fluid management technologies in space and that the mission is launched by Rocket Lab for NASA, indicating real technology validation relevance for in-space fueling or orbital servicing over a 1 year+ horizon. Why now: The membership rationale specifically points to the LOXSAT mission demonstration as the current relevance driver, citing article: but the reviewed sources does not include the article or more detailed dated evidence fields. Caveats: Underlying article is not provided in the reviewed sources. Score is based on membership rationale summary rather than available direct evidence. Single-mission validation is weaker than broad commercial traction. |
| 88 | Firefly Aerospace lowweak | Opp 4 Risk 2 | Thesis: Firefly has a positive long-horizon lunar infrastructure angle because recent article context says NASA awarded it a Moon Base contract for MoonFall, a 2028 mission to transport four drones for Artemis-site surveying. Why now: A dated May 26, 2026 article puts a fresh NASA program win into the current evidence window, which can matter over a 1 year+ horizon even if revenue realization is later. Evidence
Caveats: Only one within the recent evidence window article is available. Evidence is supporting article context rather than stronger extracted direct events. Timing of mission realization is long-dated relative to the evidence window. |
| 89 | Hispasat lowweak | Opp 4 Risk 2 | Thesis: The reviewed sources membership rationale states Hispasat is part of the IRIS2 project and will manage the LEO shell. If current, that implies meaningful strategic positioning in a long-duration European satcom infrastructure program. Why now: The only timing clue is the membership rationale referencing article, but the underlying article summary and are not included in these reviewed sources. Recency beyond the batch month label is uncertain. Caveats: No representative article or is available in the reviewed sources despite the favorable rationale. Program-role evidence can be important, but without economics or milestones the opportunity case is incomplete. |
| 90 | Impulse Space lowweak | Opp 4 Risk 4 | Thesis: Membership rationale ties Impulse Space to a Pentagon deal for space-based interceptor prototypes and identifies orbital transfer vehicle relevance, which would be strategically meaningful over a 1 year+ horizon if confirmed with current evidence, but the reviewed sources does not load the underlying evidence or article summaries after recent evidence window, unavailable in reviewed sources). Why now: Why now is only medium because defense-space prototype work can matter over a 1 year+ horizon, but the reviewed sources' available evidence is empty after recent evidence window, preventing higher-conviction ranking. Caveats: No current evidence is provided for. No direct evidence remained after the recent evidence filter. Potential opportunity rests on membership rationale rather than available corroborated evidence. |
| 91 | MDA Space Ltd. lowweak | Opp 4 Risk 3 | Thesis: MDA Space shows some opportunity context from being identified as operating in in-orbit servicing and from an article saying it won a Radarsat replenishment satellite contract, which could support durable government-space demand if current. Why now: Why-now is weak because both available representative articles are undated, so current timing and whether these items remain incremental versus already absorbed is uncertain Evidence
Caveats: Both cited articles are undated; recency is uncertain. Support is weak and based on article context, not direct positive events. No material adverse evidence is available, but no strong current catalyst is validated either. |
| 92 | Modul8 lowweak | Opp 4 Risk 3 | Thesis: Reviewed evidence membership rationale says Modul8 is a spun-out space communications unit with $40m funding, lunar cellular network deployment, and Artemis spacesuit communications work. If still current, that is among the stronger long-horizon strategic opportunity setups in this screen, but the reviewed sources does not provide citeable direct evidence or article. Why now: Among sparse names, the stated combination of funding plus lunar communications program exposure could matter over 1 year+, but recency cannot be validated from served evidence. Caveats: The strongest claims are only in membership rationale and not backed by citeable -bearing evidence in the reviewed sources. No negative evidence does not equal low fundamental risk. |
| 93 | Momentus Inc lowweak | Opp 4 Risk 5 | Thesis: Membership rationale says Momentus secured a new commercial contract for its Vigoride-9 orbital service vehicle and identifies the company as an orbital service vehicle / orbital services platform business, which would support a real opportunity thesis for space logistics if current and corroborated. However, these reviewed sources have no direct evidence or article summaries after recent evidence window, so the opportunity score must stay modest (: and: unavailable in reviewed sources). Why now: Why now is medium because an orbital services contract can matter over a 1 year+ horizon, but the reviewed sources' post-recent evidence window evidentiary absence prevents stronger timing confidence. Caveats: No direct evidence remained after the recent evidence filter. |
| 94 | NEC Corporation lowweak | Opp 4 Risk 2 | Thesis: Membership rationale states NEC launched an Orbital Transfer Vehicle development project selected by JAXA and aims for Asia's first OTV deployment. That would be a credible long-horizon strategic opportunity if current, but the reviewed sources provide no available direct evidence or article summaries inside the recent evidence window to validate progress (: unavailable in reviewed sources). Why now: Why now is medium rather than weak because an OTV development project can be durable over 1 year+, but evidentiary support in the reviewed sources are thin after recent evidence window. Caveats: No current evidence is provided for No direct evidence remained after the recent evidence filter. Current milestone timing is unverified in the reviewed sources. |
| 95 | NewOrbit Space mediummedium | Opp 4 Risk 4 | Thesis: NewOrbit Space has a plausible long-horizon opportunity because an article says it is developing satellites for very low Earth orbit and raised $18.5 million in a Series A round, suggesting both a differentiated technical focus and capital to pursue it. Why now: Why now is weaker than Aavuus because the article has no publication date. The reviewed sources explicitly says no is available and recency-sensitive claims should be treated cautiously., undated Evidence
Caveats: Evidence is supporting article context only, not direct structured positive event evidence. Publication date is unavailable; recency is uncertain. Single-article support only; no independent confirmation. |
| 96 | NorthStar Earth & Space lowweak | Opp 4 Risk 3 | Thesis: NorthStar Earth & Space appears strategically relevant to space domain awareness and may have public-market access or financing optionality via a SPAC path, but these reviewed sources provide only limited supporting article context and no strong in-window direct facts for business traction. Why now: The only dated evidence in this row is an April 27, 2026 article-level summary stating NorthStar Earth & Space plans to go public in a SPAC deal at a $300 million valuation. That may matter over a 1 year+ horizon, but the reviewed sources does not provide stronger company-specific direct evidence here. Evidence
Caveats: Coverage is extremely thin in this row: only one external article and no direct positive or negative dated events. The phase-2 rationale mentions a CAD$40M+ Royal Canadian Air Force contract, but that contract evidence is not directly surfaced in the available evidence fields for this output row, so it should not be elevated beyond the membership rationale. |
| 97 | Obruta Space Solutions lowweak | Opp 4 Risk 4 | Thesis: Obruta operates in a strategically attractive area: autonomous docking for on-orbit servicing and logistics, with stated use cases including inspection, orbital refueling, satellite life extension, debris removal, and orbital logistics. That gives a plausible long-horizon opportunity narrative if product or customer validation emerges. Why now: The only dated visible evidence is a company-site page with a May 20, 2026 describing the technology and target markets, which is relevant for strategic positioning but not enough to prove commercial inflection within the next year. Evidence
Caveats: Evidence is company-site descriptive context only. No third-party validation, financing, contract, or deployment evidence is shown. |
| 98 | Observable Space lowweak | Opp 4 Risk 4 | Thesis: Moderate opportunity based on the reviewed sources membership rationale that Observable Space was listed among notable space startup funding deals at $90 million. A funding round of that size can support growth over a 1 year+ horizon if deployed effectively. Why now: Why now is the funding mention tied to article ID: but the reviewed sources provide no, operating specifics, or additional corroborating evidence. Caveats: Funding alone is positive evidence but does not prove business quality. Article ID: is referenced without. |
| 99 | OMSPACE lowweak | Opp 4 Risk 4 | Thesis: The reviewed sources membership rationale says OMSPACE successfully launched a sounding rocket and plans an orbital launch vehicle by 2027 for small satellites. That suggests a real technical progression path if the company can convert suborbital progress into orbital capability over the next year-plus. Why now: The reviewed sources' rationale references article: for a successful sounding-rocket launch and a 2027 orbital-launch target, but the underlying article summary/ is not included here, limiting recency and sequence assessment. Caveats: Evidence is limited to a broad membership rationale without article detail. A sounding-rocket success is meaningfully earlier-stage than an orbital launch business. Risk and opportunity are both elevated relative to peers because the technology path is ambitious but still lightly evidenced. |
| 100 | Orbital lowweak | Opp 4 Risk 3 | Thesis: Orbital has modest evidence-backed opportunity because a dated within the recent evidence window article says it raised $5 million to fund an in-orbit computing demonstration next year and support initial work on its first purpose-built orbital compute satellite, Orbital-1, slated for 2028, indicating financing plus roadmap progress relevant to a 1 year+ horizon, June 10, 2026). Why now: The recency is relatively fresh: the is based on June 10, 2026, inside the 90-day recent evidence window, and it frames both new capital and a next-year demo as near-to-medium-term strategic milestones. Evidence
Caveats: All retained evidence is weak context supporting article context; there is no direct positive event/fact available. Same-article repeated rows are not independent confirmation. The opportunity case depends on an early-stage roadmap and financing announcement; commercial traction is not directly evidenced in retained rows. |
Risk view
Showing rows 161-180 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 161 | HawkEye 360, Inc. lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources lack direct positive or negative company-specific in-window operating evidence; the only retained article is weak supporting article context. That makes both upside and downside hard to validate, and uncertainty itself is the main risk. Why now: The only retained dated item is an April 5, 2026 supporting article context entry stating HawkEye 360 is a data analytics company developing space-based radio frequency mapping and a satellite constellation startup: That is too weak to establish a strong current catalyst. Caveats: Only weak supporting article context is retained after recent evidence window; no direct event/fact evidence is available. Phase2 rationale mentions 30+ satellites and government contracts, but the reviewed sources does not provide those source articles in detail here. |
| 162 | HEO lowweak | Opp 3 Risk 2 | Thesis: Risk is mainly evidentiary: the reviewed sources lack direct dated operating, financing, execution, or customer-conversion evidence, so business durability and current momentum are unclear. Why now: Why now is weak because both cited items are undated, so the reviewed sources does not establish a fresh catalyst within the current evidence window. The only support is that HEO appears in current reviewed sources context as an operating company and as associated with a contract mention, but recency cannot be confirmed from the reviewed sources Evidence
Caveats: Both supporting items are undated, so recency is uncertain. Support is supporting article context, not stronger company-specific dated event evidence. Same-article repeated rows in the reviewed sources are not independent confirmation. |
| 163 | Hispasat lowweak | Opp 4 Risk 2 | Thesis: The reviewed sources does not provide retained in-window article detail on contract economics, implementation timing, or execution risk, so the business significance cannot be scored aggressively and no direct adverse evidence is shown. Why now: The only timing clue is the membership rationale referencing article, but the underlying article summary and are not included in these reviewed sources. Recency beyond the batch month label is uncertain. Caveats: No representative article or is available in the reviewed sources despite the favorable rationale. Program-role evidence can be important, but without economics or milestones the opportunity case is incomplete. |
| 164 | HughesNet lowweak | Opp 1 Risk 2 | Thesis: Risk is mostly evidence absence rather than confirmed adverse developments: despite 104 considered articles, the reviewed sources loads zero direct negative or positive rows after recent evidence window, leaving business-state, financing, competitive, and operational risks unresolved. Why now: There is no validated near-term or long-term catalyst from active evidence. The reviewed sources cites article in membership support, but the company coverage section shows zero articles after recent evidence window and zero evidence after recent evidence window, so recency-backed thesis formation is not possible. Caveats: High article count does not equal conviction; no post-recent evidence window evidence was available. No direct company-specific event/fact evidence is available in the output reviewed sources. |
| 165 | Institute for Q-shu Pioneers of Space, Inc (iQPS) lowweak | Opp 3 Risk 2 | Thesis: No direct negative evidence is available. Residual risk comes from limited evidence depth in the ranking reviewed sources and the lack of direct operating, financing, or customer traction details after recent evidence window. Why now: Why now is only modest because launch-linked deployment could matter over a long horizon, but there are no available article summaries or dated events to establish current momentum. Caveats: Membership rationale references article IDs and, but no or summaries are provided. No direct evidence survived or were available into these reviewed sources after recent evidence window. Do not use relation context as counterparty propagation evidence. |
| 166 | Intelsat General lowweak | Opp 2 Risk 2 | Thesis: No material adverse evidence is available in the local reviewed sources, but absence of current direct evidence also prevents a strong positive thesis. Why now: Why-now support is weak because coverage data shows zero article/evidence after the 90-day recent evidence window, so recency for the cited contract context cannot be validated from available evidence. Caveats: Phase2 membership rationale references: but no representative article or evidence row is available after recent evidence window for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Scored low due to evidence absence, not due to negative business evidence. |
| 167 | Jacobs lowweak | Opp 2 Risk 2 | Thesis: There is no material adverse evidence. Risk is low-to-moderate only because current reviewed sources evidence is stale for the selected recent evidence window, not because of a negative event. Why now: Why now is weak because the contract evidence is older. The reviewed sources cites Space Force and SpaceNews articles dated June 3, 2025, which are outside the 90-day evidence window Caveats: Contract evidence exists but falls outside the selected 90-day recent evidence window. No direct positive or negative evidence remain after recent evidence filtering. |
| 168 | Jio Platforms lowweak | Opp 2 Risk 2 | Thesis: Because the reviewed sources frames Jio's satellite effort as planned and early-stage, execution and timing risk are meaningful, but the reviewed sources still lacks direct adverse evidence to score risk highly. Why now: Why now is not well supported in the served evidence because no representative articles or direct evidence are available after recent evidence window despite the membership rationale referencing article IDs, and Caveats: No representative articles or direct evidence are included in the reviewed sources output. Membership rationale is not a substitute for direct thesis evidence. Recency and event sequence cannot be judged from the missing article details. |
| 169 | K2 Space mediummedium | Opp 5 Risk 2 | Thesis: The main risk is evidence quality rather than a documented adverse event: the reviewed sources classifies the available support as weak supporting article context with neutral polarity and no direct positive or negative dated event/facts, limiting confidence in both upside magnitude and downside assessment. Why now: The evidence is recent within the 90-day recent evidence window and dated June 11, 2026 on a source date basis, which fits a 1 year+ horizon because supplier-role wins in defense satcom can matter over a longer program cycle if they convert into execution and revenue-bearing milestones. Evidence
Caveats: Available support is supporting article context with neutral polarity, not direct structured positive event/fact evidence. Only one dated article remains within the recent evidence window; same-article repeated rows are not independent confirmation. |
| 170 | Kepler Communications lowweak | Opp 3 Risk 2 | Thesis: Opportunity remains speculative because the reviewed sources offers only contextual support and no available company-specific event or fact evidence after recent evidence window; customer traction, contract value, deployment status, and monetization are not confirmed. Why now: The reviewed sources references, and: in membership support, suggesting recent strategic context, but no post-recent evidence window evidence are actually available for scoring. Caveats: Reviewed evidence itself says support is somewhat contextual. Context-only references are weaker than direct event/fact evidence. No available evidence confirms deployment, revenue, or funding milestones. |
| 171 | Korea Aerospace Industries (KAI) lowweak | Opp 2 Risk 2 | Thesis: No material adverse evidence is present in the reviewed sources. Risk is low-to-moderate only because the evidence set is empty after recent evidence window, so there is insufficient support for either a strong positive or negative thesis. Why now: Why now is weak because the reviewed sources say one article supported membership, article ID: but no, timing detail, or direct evidence were available after recent evidence window. Caveats: No direct evidence or article summaries were available after recent evidence window. Membership support references article ID: without a in the reviewed sources. |
| 172 | LiveEO lowweak | Opp 3 Risk 2 | Thesis: No direct negative evidence is provided; risk is mainly that the thesis is under-evidenced in these reviewed sources. Why now: Why-now cannot be established because no evidence remain after recent evidence filtering. Caveats: Phase2 membership rationale references, but no summary or evidence are provided for citation. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low scores reflect missing usable evidence, not a bearish business judgment. |
| 173 | Lockheed Martin mediummedium | Opp 6 Risk 2 | Thesis: The reviewed sources show no direct adverse evidence within the recent evidence window; main risk is that the support here is only supporting article context rather than stronger direct event/facts. Why now: The relevant contract article is dated April 16, 2026, inside the 90-day recent evidence window, and describes current modernization work tied to GPS IIIF support, which can matter over a multi-quarter horizon. Source date: April 16, 2026 Evidence
Caveats: Evidence is supporting article context only; no direct positive event row is available. Same article appears in multiple weak-context rows and does not count as independent confirmation. |
| 174 | Lockheed Martin Corporation lowweak | Opp 2 Risk 2 | Thesis: No material adverse evidence is available in these reviewed sources, but the absence of current direct evidence prevents a strong positive ranking. Why now: There is no available why-now evidence within the 90-day recent evidence window; coverage data shows zero evidence after recent evidence window. Caveats: Phase2 rationale cites, and, but no representative articles or evidence are available in the reviewed sources body for citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects insufficient current reviewed sources evidence, not a negative fundamental view. |
| 175 | LSS GmbH lowweak | Opp 1 Risk 2 | Thesis: Primary risk is evidentiary: the reviewed sources does not establish current business traction, financial position, or recent contract progress for LSS GmbH within the recent evidence window, so any positive thesis is highly speculative. Why now: There is no clear 'now' catalyst in the available evidence. The reviewed sources states zero article IDs after recent evidence window and zero evidence available after recent evidence window, so recency is unverified for a 1 year+ ranking. Caveats: Phase-2 rationale references consortium work tied to: and: but the reviewed sources does not include article summaries or for those items. Coverage debug shows zero evidence after recent evidence window, so no direct claim can be validated as current. Cohort review status is not a directional signal. |
| 176 | Lux Aeterna lowweak | Opp 2 Risk 2 | Thesis: Early-stage hardware execution risk is plausible, but the reviewed sources does not provide direct negative evidence inside the recent evidence window, so risk should remain low-scored. Why now: No within the recent evidence window evidence were retained for ranking, so there is no evidence-backed near-term or durable timing edge beyond generic early-stage company progress assumptions. Caveats: Membership rationale references article: but the reviewed sources does not include its or a retained evidence row. |
| 177 | Lynk Global, Inc. lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources does not describe the business model directly, so assessment risk is high; no material adverse event evidence is available after recent evidence filtering. Why now: If a rideshare payload mention reflects program progress, that could matter over 1 year+, but the reviewed sources provide no citable event details, timestamps, quote, or for article ids: and Caveats: A payload mention is more concrete than generic context, but still insufficient here because no direct evidence row or citation is included. No recent evidence window-surviving evidence exists in the reviewed sources. Slight score uplift reflects somewhat more operationally concrete context only. |
| 178 | Mach Industries lowweak | Opp 3 Risk 2 | Thesis: The same rationale also implies category ambiguity: the company is presented primarily as defense tech, so the space thesis may be overstated. No direct adverse event is available; risk is mostly execution and classification uncertainty rather than reviewed sources-proven negative developments (: not provided in reviewed sources). Why now: For a 1 year+ horizon, a large raise and mention of a satellite platform could matter if recent, but the reviewed sources does not provide usable dated evidence within the 90-day recent evidence window and explicitly reports zero available evidence after recent evidence window. Caveats: No article provided in reviewed sources. No direct event/facts are available after recent evidence window despite the membership rationale referencing a raise. Primarily defense-tech framing may limit pure-play space thesis relevance. |
| 179 | Maxar Technologies Inc. lowweak | Opp 3 Risk 2 | Thesis: Risk is mostly evidence-gap risk in these reviewed sources: without retained 90-day evidence, there is no current confirmation of contract timing, backlog conversion, program execution, or adverse developments. Why now: No retained evidence is available within the reviewed sources despite the membership rationale referencing a prior NASA deal article. That makes the name a weak current candidate under local-evidence-only rules. Caveats: No retained article summary or dated event row is provided for the cited NASA deal. Cannot elevate conviction based only on membership rationale. |
| 180 | MBRYONICS Ltd lowweak | Opp 2 Risk 2 | Thesis: The key risk is dependence on indirect role and missing evidence: the reviewed sources does not establish whether MBRYONICS is a prime beneficiary versus a component partner, and no adverse events are documented. Why now: Why now is weak because only a membership rationale references article about participation in an ESA optical communications project led by Kepler Communications, but no article or reviewed evidence is available for ranking citation. Caveats: Relation-style partnership context cannot be overused as directional proof. No article is provided for article. Coverage after recent evidence window is empty. |